封面
市场调查报告书
商品编码
1409854

2024 年组织工程全球市场报告

Tissue Engineering Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,组织工程市场规模迅速扩大。将从2023年的133.6亿美元扩大到2024年的153.8亿美元,复合年增长率为15.1%。在历史时期观察到的增长是由于生医材料的显着进步、人口老龄化的扩大、慢性病患病率的显着增加、再生医学实践的支持性监管措施以及患者对器官移植的需求增加。主要原因有以下几个因素:这些因素共同促进了组织工程和再生医学领域的成长和发展。

预计未来几年组织工程市场规模将快速成长。 2028年,将以14.4%的年复合成长率(CAGR)成长至263.3亿美元。预测期内的预期增长是由精准医疗方法的采用、对免疫调节技术的日益重视、整形外科治疗的更广泛应用、该领域的资金筹措和投资的增加以及慢性病患病率的增加所推动的。这是由于几个重要因素因素,包括:这些因素共同推动了组织工程和再生医学的预期进步。在此期间预计的主要趋势包括将奈米技术融入方法论、使用先进的3D细胞培养技术、开发和使用晶载技术、将人工智慧融入研究和应用以及创新。包括探索细胞来源。这些趋势将在预测期内塑造并推动组织工程和再生医学实践的发展。

慢性病和创伤性紧急情况的日益流行预计将推动组织工程市场的成长。慢性病的特征是持续超过 3 个月的持续临床症状,通常需要持续治疗而无需明确治疗方法。另一方面,创伤性紧急情况是指需要立即就医的突然、严重的身体伤害,例如创伤性脑损伤。医疗保健专业人员广泛采用组织工程,使用各种技术(包括自体移植物、同种异体移植物、异种移植物和合成替代品)来治疗慢性疾病和创伤。例如,根据 Mary Ann Liebert & Co. 2021 年 3 月的报告,大约 2% 的美国人口患有慢性伤口,而到 2020 年,美国疾病管制与预防中心(CDC) 记录了大约64,000 例创伤性伤口。在美国,每天约有 176 人死于脑损伤。这强调了组织工程在解决流行的慢性疾病和创伤紧急情况方面的关键作用,推动了组织工程市场的成长。

心血管疾病盛行率的上升预计将进一步促进组织工程市场的成长。心血管疾病,也称为心血管疾病 (CVD),包括影响心臟和血管的各种医疗状况。组织工程正在开发修復和再生受损心臟和血管组织的解决方案,提供有前景的治疗选择。根据世界卫生组织(WHO)统计,2021年,每年有超过1500万年龄在30岁至69岁之间的人死于非传染性疾病(NCD),其中心血管疾病是最常见的,每年有1790万人死亡。 死的。这种流行,特别是在低收入和中等收入国家,强调了对有效解决方案的需求,并进一步促进了组织工程市场的成长。组织工程市场的扩张因其在解决各种医疗状况(从慢性疾病到创伤性紧急情况和心血管疾病)方面的作用而凸显。

2023年组织工程市场最大的地区是北美。预计亚太地区将成为预测期内组织工程市场成长最快的地区。组织工程市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章组织工程市场特点

第三章 组织工程市场趋势与策略

第四章组织工程市场-宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章 全球组织工程市场规模及成长

  • 全球市场驱动因素与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章组织工程市场区隔

  • 全球组织工程市场,按类型、实际和预测细分,2018-2023、2023-2028、2033
  • 合成脚手架材料
  • 生物来源支架材料
  • 其他类型
  • 全球组织工程市场,按应用、效能和预测细分,2018-2023、2023-2028、2033
  • 整形外科和肌肉骨骼系统
  • 神经病学
  • 心血管
  • 皮肤和体被
  • 牙科
  • 其他用途
  • 全球组织工程市场,按最终用户细分,实际和预测,2018-2023、2023-2028、2033
  • 医院和诊所
  • 门诊设施

第 7 章:组织工程市场区域与国家分析

  • 全球组织工程市场,按地区、绩效及预测,2018-2023、2023-2028、2033
  • 全球组织工程市场,依国家、绩效及预测,2018-2023、2023-2028、2033

第八章亚太组织工程市场

第九章中国组织工程市场

第十章 印度组织工程市场

第十一章 日本组织工程市场

第十二章 澳洲组织工程市场

第十三章 印尼组织工程市场

第14章 韩国组织工程市场

第十五章西欧组织工程市场

第十六章英国组织工程市场

第十七章 德国组织工程市场

第十八章 法国组织工程市场

第十九章 义大利组织工程市场

第二十章 西班牙组织工程市场

第21章东欧组织工程市场

第22章 俄罗斯组织工程市场

第23章北美组织工程市场

第24章美国组织工程市场

第25章加拿大组织工程市场

第26章 南美洲组织工程市场

第27章 巴西组织工程市场

第28章中东组织工程市场

第29章 非洲组织工程市场

第30章组织工程市场的竞争形势与公司概况

  • 组织工程市场竞争形势
  • 组织工程市场公司概况
    • Medtronic plc
    • Zimmer Biomet
    • Allergan plc
    • Organogenesis Holdings Inc.
    • Integra LifeSciences

第31章全球组织工程市场的竞争基准化分析

第32章全球组织工程市场竞争仪表板

第三十三章组织工程市场重大併购

第34章组织工程市场未来展望及潜力分析

第35章附录

简介目录
Product Code: r11392

“Tissue Engineering Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineering market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineering? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tissue engineering market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Synthetic Scaffold Material; Biologically Derived Scaffold Material; Other Types
  • 2) By Application: Orthopedics And Musculoskeletal; Neurology; Cardiovascular; Skin And Integumentary; Dental; Other Applications;;
  • 3) By End-User: Hospitals And Clinics; Ambulatory Facilities
  • Companies Mentioned: Medtronic plc; Zimmer Biomet; Allergan plc; Organogenesis Holdings Inc.; Integra LifeSciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Tissue engineering is a specialized field within biomedical engineering that combines biological and engineering methodologies. It aims to generate three-dimensional tissue and cellular products both in vivo (within a living organism) and in vitro (outside a living organism) by modifying cell growth conditions and utilizing appropriate cell isolates from donor tissues alongside biocompatible scaffold materials. The primary objective is to restore, repair, maintain, or enhance tissue function by replacing or regenerating damaged tissues, thereby improving human body functions.

Key categories within tissue engineering encompass synthetic scaffold materials, biologically derived scaffold materials, and other methodologies. Synthetic scaffold materials are synthetic polymers composed of fibrous proteins that simulate an extracellular matrix, promoting favorable cellular responses and behaviors in tissue engineering applications. These materials find diverse applications across orthopedics and musculoskeletal treatments, neurology, cardiovascular procedures, skin and integumentary therapies, dental applications, among others. Various end-users including hospitals, clinics, and ambulatory facilities utilize these materials for their respective medical applications.

The tissue engineering market research report is one of a series of new reports from The Business Research Company that provides tissue engineering market statistics, including the tissue engineering industry global market size, regional shares, competitors with a tissue engineering market share, detailed tissue engineering market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering industry. This tissue engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue engineering market size has grown rapidly in recent years. It will grow from $13.36 billion in 2023 to $15.38 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed in the historic period can be primarily attributed to several factors, including significant advancements in biomaterials, the expanding aging population demographic, a notable increase in the prevalence of chronic diseases, supportive regulatory measures for regenerative medicine practices, and a rising demand from patients for organ transplants. These elements collectively contributed to the growth and development within the field of tissue engineering and regenerative medicine.

The tissue engineering market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period can be attributed to several key factors, including the adoption of precision medicine approaches, a heightened emphasis on immunomodulation techniques, broader applications within orthopedic treatments, augmented funding and investment in the field, and a growing incidence of chronic diseases. These factors collectively drive the anticipated advancements within tissue engineering and regenerative medicine. Major trends expected during this period encompass the integration of nanotechnology into methodologies, the utilization of advanced 3D cell culture techniques, the development and utilization of organ-on-a-chip technology, the integration of artificial intelligence in research and applications, and the exploration of innovative cell sources. These trends are poised to shape and drive the evolution of tissue engineering and regenerative medicine practices in the forecasted period.

The anticipated increase in the prevalence of chronic diseases and trauma emergencies is poised to drive the growth of the tissue engineering market. Chronic diseases are characterized by enduring clinical conditions that persist for three months or longer, often requiring ongoing management without definitive cures. Conversely, trauma emergencies refer to sudden and severe physical injuries necessitating immediate medical attention, such as traumatic brain injuries. Healthcare professionals widely adopt tissue engineering for treating chronic disorders and trauma, employing various techniques such as autologous or allograft transplantation, xenotransplantation, and artificial substitutes. For example, a March 2021 report from Mary Ann Liebert, Inc. indicated that approximately 2% of the total U.S. population is affected by chronic wounds, while in 2020, the Centers for Disease Control and Prevention (CDC) recorded around 64,000 traumatic brain injuries in the United States, resulting in approximately 176 deaths daily due to TBI. This underscores the critical role of tissue engineering in addressing prevalent chronic diseases and trauma emergencies, driving the growth of the tissue engineering market.

The rising prevalence of cardiovascular disorders is expected to further contribute to the growth of the tissue engineering market. Cardiovascular disorders, also known as cardiovascular diseases (CVD), encompass various medical conditions affecting the heart and blood vessels. In tissue engineering, solutions are developed to repair and regenerate damaged cardiac and vascular tissues, offering promising treatment options. According to the World Health Organization in 2021, more than 15 million people aged 30 to 69 die annually from non-communicable diseases (NCDs), with cardiovascular disease being the most common, causing 17.9 million deaths each year. This prevalence, particularly in low- and middle-income countries, emphasizes the demand for effective solutions, further driving the growth of the tissue engineering market. The tissue engineering market's expansion is underscored by its role in addressing a spectrum of medical conditions, from chronic diseases to trauma emergencies and cardiovascular disorders.

Technological advancement stands out as a prominent trend gaining momentum in the tissue engineering market. Major companies within the industry are placing a significant focus on research and development to drive product innovations, providing enhanced solutions and solidifying their market positions. An example of this commitment is CELLINK, a U.S.-based company specializing in tissue engineering, which introduced its advanced bioprinter in March 2021. The BIO MDX Series, operating on 3D bioprinting technology, utilizes bio-inks and living cells to construct natural 3D tissue structures. This innovative technology comprises printheads, nanoliter and picoliter dispensing channels, and robotic integration, enabling precision bioprinting for high-throughput fabrication. The utilization of advanced bioprinting technologies reflects the industry's dedication to pushing the boundaries of tissue engineering for improved outcomes in cell-based technologies.

Major companies are strategically engaging in partnerships and collaborations with start-ups and mid-sized companies to expand their product and service offerings in the tissue engineering market. These collaborative efforts play a crucial role in broadening companies' product portfolios and extending their geographical reach. An illustrative instance is the collaboration agreement between Regen Lab, a Swiss-based medical technology company specializing in tissue engineering, Long Island University (LIU), and the Dassault Systemes Group (3DS) in June 2023. Under this agreement, LIU and RegenLab USA join forces to establish an industrial innovation accelerator, a new center of excellence dedicated to regenerative medicine and tissue engineering. Such strategic collaborations enhance the capabilities and offerings of companies in the tissue engineering market, fostering innovation and growth. LIU, based in the U.S., and Dassault Systemes Group, a French software corporation, are key partners in this initiative.

In October 2022, Geistlich Pharma, a US-based company specializing in bone, cartilage, and tissue regeneration, completed the acquisition of Lynch Biologics, LLC. The financial specifics of this acquisition were not disclosed. This strategic move serves to bolster Geistlich's existing regenerative product portfolio and augments its growth prospects within the field. Lynch Biologics, the acquired company, is also based in the US and is known for its focus on regenerative medicine and tissue engineering. They specialize in supplying advanced biotechnology products aimed at fostering healing and tissue regeneration.

Major companies operating in the tissue engineering market report are Medtronic plc, Zimmer Biomet, Allergan plc, Organogenesis Holdings Inc., Integra LifeSciences, Stryker Corporation, DePuy Synthes Companies, Acelity L.P. Inc., B. Braun Melsungen AG, RTI Surgical Inc., AbbVie Inc., Becton Dickinson and Company, Baxter International Inc., Osiris Therapeutics Inc., Organovo Inc., BioTime Inc., Bio Tissue Technologies, Vericel Corporation, Smith and Nephew, Acell Inc., Athersys Inc., Tissue Regenix Group plc, Xeltis AG, Prellis Biologics, Butterfly Network Inc., iThera Medical GmbH, Bit Bio, Be Biopharma Inc., The Takeda Pharmaceutical Company, Frequency Therapeutics, TELA Bio Inc., Orthocell Limited .

North America was the largest region in the tissue engineering market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue engineering market during the forecast period. The regions covered in the tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tissue engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue engineering market consists of sales of reparative cells, bioreactive molecules, such as cytokines, growth factors, biomaterials, and bioreactors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Tissue Engineering Market Characteristics

3. Tissue Engineering Market Trends And Strategies

4. Tissue Engineering Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Tissue Engineering Market Size and Growth

  • 5.1. Global Tissue Engineering Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Tissue Engineering Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Tissue Engineering Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tissue Engineering Market Segmentation

  • 6.1. Global Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Synthetic Scaffold Material
  • Biologically Derived Scaffold Material
  • Other Types
  • 6.2. Global Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Orthopedics And Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin And Integumentary
  • Dental
  • Other Applications
  • 6.3. Global Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Facilities

7. Tissue Engineering Market Regional And Country Analysis

  • 7.1. Global Tissue Engineering Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Tissue Engineering Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tissue Engineering Market

  • 8.1. Asia-Pacific Tissue Engineering Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tissue Engineering Market

  • 9.1. China Tissue Engineering Market Overview
  • 9.2. China Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tissue Engineering Market

  • 10.1. India Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tissue Engineering Market

  • 11.1. Japan Tissue Engineering Market Overview
  • 11.2. Japan Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tissue Engineering Market

  • 12.1. Australia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tissue Engineering Market

  • 13.1. Indonesia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tissue Engineering Market

  • 14.1. South Korea Tissue Engineering Market Overview
  • 14.2. South Korea Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tissue Engineering Market

  • 15.1. Western Europe Tissue Engineering Market Overview
  • 15.2. Western Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tissue Engineering Market

  • 16.1. UK Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tissue Engineering Market

  • 17.1. Germany Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tissue Engineering Market

  • 18.1. France Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tissue Engineering Market

  • 19.1. Italy Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tissue Engineering Market

  • 20.1. Spain Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tissue Engineering Market

  • 21.1. Eastern Europe Tissue Engineering Market Overview
  • 21.2. Eastern Europe Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tissue Engineering Market

  • 22.1. Russia Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tissue Engineering Market

  • 23.1. North America Tissue Engineering Market Overview
  • 23.2. North America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tissue Engineering Market

  • 24.1. USA Tissue Engineering Market Overview
  • 24.2. USA Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tissue Engineering Market

  • 25.1. Canada Tissue Engineering Market Overview
  • 25.2. Canada Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tissue Engineering Market

  • 26.1. South America Tissue Engineering Market Overview
  • 26.2. South America Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tissue Engineering Market

  • 27.1. Brazil Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tissue Engineering Market

  • 28.1. Middle East Tissue Engineering Market Overview
  • 28.2. Middle East Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tissue Engineering Market

  • 29.1. Africa Tissue Engineering Market Overview
  • 29.2. Africa Tissue Engineering Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Tissue Engineering Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Tissue Engineering Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tissue Engineering Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Engineering Market Competitive Landscape
  • 30.2. Tissue Engineering Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Zimmer Biomet
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Allergan plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Organogenesis Holdings Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Integra LifeSciences
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Tissue Engineering Market Competitive Benchmarking

32. Global Tissue Engineering Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineering Market

34. Tissue Engineering Market Future Outlook and Potential Analysis

  • 34.1 Tissue Engineering Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Tissue Engineering Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Tissue Engineering Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer